Interested Stockholder. As of the date hereof, such Purchaser is not an “interested stockholder” (as defined in Section 203(c)(5) of the General Corporation Law of the State of Delaware) of the Company.
Appears in 3 contracts
Samples: Warrant Purchase Agreement (Kennedy-Wilson Holdings, Inc.), Warrant Purchase Agreement (Kennedy-Wilson Holdings, Inc.), Preferred Stock Purchase Agreement (Kennedy-Wilson Holdings, Inc.)
Interested Stockholder. As of the date hereof, such Such Purchaser is not an “interested stockholderInterested Stockholder” (as such term is defined in Section 203(c)(5) 203 of the General Corporation Law of the State of Delaware) of the Company).
Appears in 2 contracts
Samples: Securities Purchase Agreement (Yumanity Therapeutics, Inc.), Securities Purchase Agreement (Exicure, Inc.)
Interested Stockholder. As of the date hereof, such Such Purchaser is not an “interested stockholderInterested Stockholder” (as such term is defined in Section 203(c)(5) 203 of the General Corporation Law of the State of Delaware) of the Company.). 4856-1855-5126.3
Appears in 1 contract
Interested Stockholder. As of the date hereof, such Such Purchaser is not an “interested stockholderInterested Stockholder” (as such term is defined in Section 203(c)(5) 203 of the General Corporation Law of the State of Delaware) of the Company.). 4933-6568-3202.3
Appears in 1 contract
Interested Stockholder. As of the date hereof, such the Purchaser is not an “interested stockholder” (as defined in Section 203(c)(5) of the General Corporation Law of the State of Delaware) of the Company.
Appears in 1 contract
Samples: Equity Commitment and Investment Agreement (Catalent, Inc.)
Interested Stockholder. As of the date hereof, such Such Purchaser is hereby will not become an “interested stockholder” (as defined in within the meaning of Section 203(c)(5) 203 of the Delaware General Corporation Law as a result of the State purchase of Delaware) of the CompanyShares under this Agreement.
Appears in 1 contract
Samples: Securities Purchase Agreement (Monopar Therapeutics)
